注册 | 登录 | 充值

返回首页
找到约 157 条结果

2020 HOW WE TREAT 肉瘤大型网络云会议重磅召开!

整理:肿瘤资讯来源:肿瘤资讯2020年,由于突如其来的疫情限制,影响了学术交流。为了能够满足广大专注于肉瘤研究及治疗的医生学术交流的强烈需求,由中国临床肿瘤学会(CSCO)肉瘤专家委员会主办、良医汇承办的“2020 ..... 
学术资讯 - 临床医学

2020ASCO——晚期NSCLC免疫治疗篇(上)

编译:李峻岭来源: 医科院肿瘤医院李峻岭医生李峻岭教授带来2020 ASCO晚期非小细胞肺癌免疫治疗研究进展解读。摘要号9500Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for ..... 
学术资讯 - 临床医学

ATHENA研究:决奈达隆对于房颤患者心血管事件的影响

Background: Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation.Methods: We conducted a multicenter trial to evaluate the use of dronedarone in 4628 pat..... 
学术资讯 - 临床研究

STITCH研究:高血压阶梯治疗方案较加拿大指南更有效

Simplified Treatment Intervention to Control Hypertension(STITCH)研究结果显示,与基于指南的临床实践相比,简化的高血压阶梯治疗方案降低血压更为有效。STITCH研究者试图探索一种治疗高血压的理想方案,较指南更为简单易行,从而..... 
学术资讯 - 临床研究

CARMEN试验:卡维地洛和ACE抑制剂改变轻度心衰评估试验原理及设计The Carvedilol and ACE

Inhibition or reversal of ventricular remodelling in heart failure patients is regarded as of prime importance in the treatment of heart failure and in determining long term outcome. Recent studies have demonstrate..... 
学术资讯 - 临床研究

CARMEN:卡维地洛和ACE抑制剂早期联合治疗在轻度心衰及左室收缩功能障碍中获益。卡维地洛和ACE抑制剂改变轻度心衰评估试验

 AIMS: Heart failure (HF) treatment guidelines of the ESC recommend ACE-inhibitors (ACE-I) as first-line treatment and beta-blockers added if patients remain symptomatic. CARMEN exp..... 
学术资讯 - 临床研究

PCI

Context The benefit of clopidogrel pretreatment before percutaneous coronary intervention (PCI) remains debated and its use has not been universally adopted.Objective: To determine if clopidogrel pretreatment before PCI ..... 
学术资讯 - 临床研究

RITA:Interventional versus conservative treatment for patients with unstable angina or non

K A A Fox, P A Poole-Wilson, R A Henderson, T C Clayton, D A Chamberlain, T R D Shaw, D J Wheatley, S J Pocock, for the Randomized Intervention Trial of unstable Angina (RITA) investigators*Summary..... 
学术资讯 - 临床研究

Treating to New Targets(TNT) Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease

当前位置:循环首页>正文 Treating to New Targets(TNT)Intensive Lipid Lowering with Atorvastatinin Patients with Stable ..... 
学术资讯 - 临床研究

TNT:Treating to New Targets(TNT)Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease

New Eng J Med.2005; Early release Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease John C. LaRosa, et al.Background :Previous trials have demonst..... 
学术资讯 - 临床研究